Kenneth J. Pienta
Chief Tech/Sci/R&D Officer bei James Buchanan Brady Urological Institute
Profil
Kenneth J.
Pienta is currently the Research Director at James Buchanan Brady Urological Institute and a Professor at The Johns Hopkins University.
He previously held positions as the Director-Prostate Specialized Program at the University of Michigan, Director-Experimental Therapeutics at Michigan Center for Translational Pathology, and Independent Director at Curis, Inc. He was also a Director at GreenMark Biomedical, Inc. and is currently the Chief Medical Officer at Cue Biopharma, Inc. Pienta received his undergraduate degree from The Johns Hopkins University and his doctorate from The Johns Hopkins University School of Medicine.
Aktive Positionen von Kenneth J. Pienta
Unternehmen | Position | Beginn |
---|---|---|
James Buchanan Brady Urological Institute | Chief Tech/Sci/R&D Officer | 01.03.2013 |
The Johns Hopkins University | Corporate Officer/Principal | 01.01.1994 |
Ehemalige bekannte Positionen von Kenneth J. Pienta
Unternehmen | Position | Ende |
---|---|---|
CUE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 17.01.2023 |
GreenMark Biomedical, Inc.
GreenMark Biomedical, Inc. BiotechnologyHealth Technology GreenMark Biomedical, Inc. operates as a healthcare company. It develops technologies that involve small biopolymer particles produced from food grade starch. The firm?s diagnostic product is used by dental professionals as part of the routine dental exam, assess, and monitor non-invasive treatment of dental caries. The company was founded by Steven Bloembergen in March 2016 and is headquartered in East Lansing, MI. | Director/Board Member | 01.01.2020 |
CURIS, INC. | Director/Board Member | 01.05.2017 |
Michigan Center for Translational Pathology | Corporate Officer/Principal | 01.02.2013 |
University of Michigan | Corporate Officer/Principal | - |
Ausbildung von Kenneth J. Pienta
The Johns Hopkins University | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CURIS, INC. | Health Technology |
CUE BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Michigan Center for Translational Pathology | |
GreenMark Biomedical, Inc.
GreenMark Biomedical, Inc. BiotechnologyHealth Technology GreenMark Biomedical, Inc. operates as a healthcare company. It develops technologies that involve small biopolymer particles produced from food grade starch. The firm?s diagnostic product is used by dental professionals as part of the routine dental exam, assess, and monitor non-invasive treatment of dental caries. The company was founded by Steven Bloembergen in March 2016 and is headquartered in East Lansing, MI. | Health Technology |